COTINGA PHARMA Revenue, Profits - COTQF Annual Income Statement

Add to My Stocks
$0.16 $0 (0%) COTQF stock closing price Sep 17, 2018 (Closing)

Fundamental analysis of COTQF stock involves analyzing its financial statements, apart from checking the COTINGA PHARMA stock price. In the income statement, an investor can look at important parameters like revenue or sales, gross profits, net profits, and EPS basic to gain deeper insights. The income statement is always for an accounting period, typically for a year or quarter, and affects the stock. In this case, the COTQF stock is bound to reflect the impact of the YOY decline of 0. Revenue for year 2017 is $- and has decreased from $- year on year as is evident when you compare the latest figures in the latest COTINGA PHARMA profit and loss statement with those of the prior corresponding period. Also see COTINGA PHARMA assets and COTINGA PHARMA free cash flow for a complete valuation of COTQF stock.

View revenue and profit details for latest and last 10 financial years.
show more
Fiscal year is May - Apr201720162015
COTINGA PHARMA Revenues or Net Sales
---
Cost Of Goods Sold (COGS)---
COTINGA PHARMA Gross Profit
---
Research & Development Expense2.06M1.14M1.18M
Selling General & Admin Expense3.19M1.84M2.29M
Income Before Depreciation Depletion Amortization-5.26M-2.98M-3.47M
Depreciation Depletion Amortization---
Non Operating Income--0.76M-
Interest Expense---
COTINGA PHARMA Pretax Income
-4.71M-3.74M-3.32M
Provision for Income Taxes---
MinorityInterest---
Investment Gains Losses---
Other Income---
Income Before Extraordinaries & Disc Operations-4.71M-3.74M-3.32M
Extraordinary Items & Discontinued Operations---
COTINGA PHARMA Profit/ Loss (Net Income)
-4.71M-3.74M-3.32M
Average Shares used to compute Diluted EPS14.78M12.31M10.87M
Average Shares used to compute Basic EPS14.78M12.31M10.87M
Income Before Nonrecurring Items-4.67M-3.77M-3.33M
Income from Nonrecurring Items---
COTINGA PHARMA Earnings Per Share Basic Net
-0.32-0.30-0.30
COTINGA PHARMA Earnings Per Share Diluted Net
-0.32-0.30-0.30
EPS Diluted Before Nonrecurring Items-0.32-0.30-0.30
Preferred Dividends Acc Pd---
Dividends Common---
Dividend Per Share Common0.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.

Click here to view our Intrexon financial analysis

The key things to look for in an income statement while doing COTINGA PHARMA stock analysis are:

  • Topline: A growing topline, as seen from the COTINGA PHARMA revenue chart, as isn't the case with COTINGA PHARMA indicates a sagging business. One needs to compare the YoY topline or sales growth of COTQF stock with its peers like CXRXD stock and BINDQ stock to see if the growth compares well with what can be expected from a company in that industry.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. COTQF stock had a poor bottom line growth.

The income statement is also called the profit and loss statement. Apart from the COTQF income statement, one can check the COTINGA PHARMA historical stock prices to check how the price has moved with time.

COTINGA PHARMA Income Statement - Key Financial Ratios